气道微生物组组成和共发生网络与喘炎症表型有关
Yi Li1, Congying Zou2, Jieying Li3
1State Key Laboratory of Severe Weather of CMA, Chinese Academy of Meteorological Sciences, Beijing, China.
International archives of allergy and immunology
|September 10, 2023
概括
呼吸道微生物组组成和网络在喘炎症表型之间有所不同. 这些细菌差异可能会影响喘的严重程度和治疗,建议基于气道细菌的个性化疗法.
科学领域:
- 微生物学 微生物学
- 免疫学 免疫学 免疫学
- 肺部病理学 肺部病理学
背景情况:
- 呼吸道微生物组的组成和相互作用可能会影响喘的炎症特征.
- 呼吸道细菌群落在喘表型之间有所不同,可能会影响治疗结果.
- 研究呼吸道微生物群对于了解喘的炎症机制至关重要.
研究的目的:
- 为了比较不同喘炎症表型之间的呼吸道微生物组合和功能.
- 为了确定细菌共发生网络和预测代谢途径的差异.
- 探索呼吸道微生物群与喘炎症之间的关系.
主要方法:
- 从喘患者和健康对照中诱导的唾液中分析细菌微生物群.
- 微生物组多样性,组成,并发网络和KEGG通路的比较.
- 根据部分呼出的氧化 (FeNO) 含量对喘患者进行分层分类.
主要成果:
- 在低和高FeNO组之间发现了液微生物组合,共发生网络和预测的功能途径的显著差异.
- 低FeNO组显示出较低的α多样性和更高的蛋白质细菌丰度.
- 高FeNO组表现出更连接的共发生网络,并改变了像T. socranskii这样的关键物种的丰度.
结论:
- 气道微生物群的组成和网络结构与不同的喘炎症表型有关.
- 微生物组的差异可能会影响喘进展和治疗反应.
- 基于呼吸道细菌属的向治疗可能是喘管理的未来方向.
相关概念视频
Asthma-II: Pathophysiology and Classification
2.7K
Asthma is a prevalent chronic respiratory condition marked by inflammation and hyperresponsiveness of the airways. Its pathophysiology involves complex interactions among inflammatory pathways, immune responses, and neural mechanisms.
Additionally, environmental and genetic factors play crucial roles in determining an individual's susceptibility to asthma and the severity of their condition.
Critical processes in asthma pathophysiology include:
Additionally, environmental and genetic factors play crucial roles in determining an individual's susceptibility to asthma and the severity of their condition.
Critical processes in asthma pathophysiology include:
2.7K
Asthma-I: Introduction
2.7K
Asthma is a chronic respiratory ailment that requires careful management due to its varying symptoms and influencing factors. It is characterized by airway inflammation, bronchial hyperresponsiveness, and reversible airflow obstruction, leading to symptoms like wheezing, shortness of breath, chest tightness, and coughing. The symptom frequency and intensity may vary considerably over time. It is also linked to immune system responses to allergens and irritants, highlighting the complex...
2.7K
Asthma: Pathogenesis and Management
439
Asthma is a chronic pulmonary condition involving inflammation of the airways, hyper-reactivity, and reversible obstruction of the airways. This condition can significantly impact a person's quality of life, making breathing difficult and leading to distressing symptoms.
Asthma is classified as allergic and non-allergic. Allergens such as dust mites, pollen, and pet dander trigger allergic asthma, while factors like cold air, intense emotions, or exercise can induce non-allergic asthma.
Asthma is classified as allergic and non-allergic. Allergens such as dust mites, pollen, and pet dander trigger allergic asthma, while factors like cold air, intense emotions, or exercise can induce non-allergic asthma.
439
Chronic Obstructive Pulmonary Disease-II: Pathophysiology
2.8K
Chronic Obstructive Pulmonary Disease (COPD) pathophysiology is intricate and multifaceted, involving a complex interplay of physiological processes. Understanding these mechanisms is crucial for effectively managing and treating COPD. Here is an in-depth look at the critical elements in the pathophysiology of COPD:
Chronic Inflammation
Chronic Inflammation
2.8K
Asthma-III: Symptoms and Complications
2.5K
Asthma, a common chronic respiratory condition, is classified considering the frequency and severity of symptoms alongside lung function impairment. Understanding this classification is essential for appropriate treatment and management. Here's a detailed look at the classification of asthma and its clinical features and complications:
Classification of Asthma
Classification of Asthma
2.5K
Asthma-IV: Diagnostic and Management
2.5K
The diagnosis and management of asthma are comprehensive, encompassing clinical assessments, lung function tests, and pharmacological interventions. Here's an overview:
Clinical Assessment for Asthma:
This is the first step in diagnosing and managing asthma. It includes:
Clinical Assessment for Asthma:
This is the first step in diagnosing and managing asthma. It includes:
2.5K


